These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29598935)

  • 21. Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure.
    Mealing S; Woods B; Hawkins N; Cowie MR; Plummer CJ; Abraham WT; Beshai JF; Klein H; Sculpher M
    Heart; 2016 Nov; 102(21):1742-1749. PubMed ID: 27411837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left bundle branch block criteria in the 2021 ESC guidelines on CRT: a step back in identifying CRT candidates?
    Beela AS; Rijks JHJ; Manetti CA; Vernooy K; van Stipdonk AMW; Prinzen FW; Delhaas T; Herbots L; Lumens J
    Eur Heart J Cardiovasc Imaging; 2024 Aug; 25(9):e213-e215. PubMed ID: 38961759
    [No Abstract]   [Full Text] [Related]  

  • 23. Relation of QRS Duration to Response to Cardiac Resynchronization Therapy in Patients With Left Bundle Branch Block.
    Sassone B; Bertini M; Beltrami M; Malagù M; Pasanisi G; Kuwornu HA; Avigni N; Fucà G; Pacchioni F; Minarelli M; Bacchi Reggiani ML; Padeletti L
    Am J Cardiol; 2017 Jun; 119(11):1803-1808. PubMed ID: 28391991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular lead position and nonspecific conduction delay are predictors of mortality in patients during cardiac resynchronization therapy.
    Prochnau D; Kuehnert H; Heinke M; Figulla HR; Surber R
    Can J Cardiol; 2011; 27(3):363-8. PubMed ID: 21507601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic benefit of cardiac resynchronization therapy is greater in concordant vs. discordant left bundle branch block in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Padeletti L; Aimo A; Vishenvsky B; Schwartz A; McNitt S; Wang PJ; Moss AJ; Emdin M; Zareba W
    Europace; 2018 May; 20(5):794-800. PubMed ID: 28398490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Size Matters: Normalization of QRS Duration to Left Ventricular Dimension Improves Prediction of Long-Term Cardiac Resynchronization Therapy Outcome.
    Zweerink A; Friedman DJ; Klem I; van de Ven PM; Vink C; Biesbroek PS; Hansen SM; Emerek K; Kim RJ; van Rossum AC; Atwater BD; Nijveldt R; Allaart CP
    Circ Arrhythm Electrophysiol; 2018 Dec; 11(12):e006767. PubMed ID: 30541355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probability and magnitude of response to cardiac resynchronization therapy according to QRS duration and gender in nonischemic cardiomyopathy and LBBB.
    Varma N; Manne M; Nguyen D; He J; Niebauer M; Tchou P
    Heart Rhythm; 2014 Jul; 11(7):1139-47. PubMed ID: 24704570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect on cardiac function of cardiac resynchronization therapy in patients with right bundle branch block (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT] trial).
    Tompkins C; Kutyifa V; McNitt S; Polonsky B; Klein HU; Moss AJ; Zareba W
    Am J Cardiol; 2013 Aug; 112(4):525-9. PubMed ID: 23725995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
    Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRT Survey II: a European Society of Cardiology (ESC) survey of cardiac resynchronization therapy-an Irish subset analysis.
    Ranganathan D; Sharif Z; Murphy T; Mahon N; Sheahan CR; Normand C; Linde C; Dickstein K; Sheahan R
    Ir J Med Sci; 2020 Aug; 189(3):895-905. PubMed ID: 31981072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained clinical benefit of cardiac resynchronization therapy in non-LBBB patients with prolonged PR-interval: MADIT-CRT long-term follow-up.
    Stockburger M; Moss AJ; Klein HU; Zareba W; Goldenberg I; Biton Y; McNitt S; Kutyifa V
    Clin Res Cardiol; 2016 Nov; 105(11):944-952. PubMed ID: 27318807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric Dilated Cardiomyopathy Patients Do Not Meet Traditional Cardiac Resynchronization Criteria.
    Schiller O; Dham N; Greene EA; Heath DM; Alexander ME; Berul CI
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):885-889. PubMed ID: 25884372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac-resynchronization therapy in patients with systolic heart failure and QRS interval ≤130 ms: insights from a meta-analysis.
    Shah RM; Patel D; Molnar J; Ellenbogen KA; Koneru JN
    Europace; 2015 Feb; 17(2):267-73. PubMed ID: 25164431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
    Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
    Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume.
    Bogale N; Priori S; Gitt A; Alings M; Linde C; Dickstein K;
    Europace; 2011 Oct; 13(10):1445-53. PubMed ID: 21712274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eligibility of cardiac resynchronization therapy patients for subcutaneous implantable cardioverter defibrillators.
    Giammaria M; Lucciola MT; Amellone C; Orlando F; Mazzone G; Chiarenza S; Lovecchio M; Valsecchi S
    J Interv Card Electrophysiol; 2019 Jan; 54(1):49-54. PubMed ID: 30187250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Long-Term Survival Benefits With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Versus Without Diabetes Mellitus (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT]).
    Kutyifa V; Naqvi SY; Brown M; McNitt S; Goldenberg I; Klein H; Moss AJ
    Am J Cardiol; 2018 Jun; 121(12):1567-1574. PubMed ID: 29625702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of the PR Interval in Patients Receiving Cardiac Resynchronization Therapy: Results From the REVERSE Study.
    Senfield J; Daubert C; Abraham WT; Ghio S; St John Sutton M; Cerkvenik J; Linde C; Gold MR
    JACC Clin Electrophysiol; 2017 Aug; 3(8):818-826. PubMed ID: 29759777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete left bundle branch block and smaller left atrium are predictors of response to cardiac resynchronization therapy in advanced heart failure.
    Imamura T; Kinugawa K; Nitta D; Komuro I
    Circ J; 2015; 79(11):2414-21. PubMed ID: 26376671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Don't expect left ventricular reverse remodeling after cardiac resynchronization therapy in patients with systolic heart failure and atrioventricular block: A multicenter study.
    Sairaku A; Yoshida Y; Nakano Y; Hirayama H; Maeda M; Hashimoto H; Kihara Y
    Int J Cardiol; 2016 Oct; 221():597-600. PubMed ID: 27420585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.